The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Imatinib Mesylate — A New Oral Targeted Therapy
Abstract
This review discusses the development and uses of imatinib mesylate, a protein tyrosine kinase inhibitor useful in the treatment of chronic myelogenous leukemia and gastrointestinal stromal tumors that was recently approved by the Food and Drug Administration. Imatinib targets platelet-derived growth factor receptor, inhibits the fusion product of the Philadelphia chromosome, and targets c-kit, a protein tyrosine kinase. The drug may also be effective in the treatment of other tumors that express platelet-derived growth factor receptor or c-kit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Goycoolea, A. (1997) · Cited by 3,615
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
A minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Joensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
The molecular biology of chronic myeloid leukemia
Deininger, M. W. N., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.10.3343 · Cited by 1,667
Sawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,621
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
The Biology of Chronic Myeloid Leukemia
Faderl, S., Talpaz, M., Estrov, Z., O'Brien, S., Kurzrock, R., & Kantarjian, H. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410306 · Cited by 1,302
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
Buchdunger, E., Cioffi, C. L., Law, N., Stover, D., Ohno-Jones, S., Druker, B. J., & Lydon, N. B. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38879-2 · Cited by 1,274
van Oosterom, A. T., Judson, I., Verweij, J., Stroobants, S., di Paola, E. D., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06535-7 · Cited by 1,264
Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,071
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Druker, B. J., & Lydon, N. (1996) · PubMed · Cited by 1,057
Heisterkamp, N., Stephenson, J. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. R., & Grosveld, G. (1983) · Nature · doi:10.1038/306239a0 · Cited by 842
Gastrointestinal stromal tumors: Recent advances in understanding of their biology
Miettinen, M., Sarlomo-Rikala, M., & Lasota, J. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90040-0 · Cited by 840
Bartram, C. R., de Klein, A., Hagemeijer, A., van Agthoven, T., van Kessel, A. G., Bootsma, D., Grosveld, G., Ferguson-Smith, M. A., Davies, T., Stone, M., et al. (1983) · Nature · doi:10.1038/306277a0 · Cited by 747
Druker, B. J., & Lydon, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 707
Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90689-n · Cited by 659
Talpaz, M., Kantarjian, H. M., McCredie, K., Trujillo, J. M., Keating, M. J., & Gutterman, J. U. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604243141701 · Cited by 647
Gratwohl, A., Hermans, J., Goldman, J., Arcese, W., Carreras, E., Devergie, A., Frassoni, F., Gahrton, G., Kolb, H., Niederwieser, D., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03030-x · Cited by 646
Prognosis of Gastrointestinal Smooth-Muscle (Stromal) Tumors: Dependence on Anatomic Site
Emory, T. S., Sobin, L. H., Lukes, L., Lee, D. H., & O'Leary, T. J. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199901000-00009 · Cited by 625
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
Aricò, M., Valsecchi, M. G., Camitta, B., Schrappe, M., Chessells, J., Baruchel, A., Gaynon, P., Silverman, L., Janka-Schaub, G., Kamps, W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004063421402 · Cited by 600
Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase Inhibitors
Yaish, P., Gazit, A., Gilon, C., & Levitzki, A. (1988) · Science · doi:10.1126/science.3263702 · Cited by 587
Mahon, F. X., Deininger, M. W. N., Schultheis, B., Chabrol, J., Reiffers, J., Goldman, J. M., & Melo, J. V. (2000) · Blood · doi:10.1182/blood.v96.3.1070 · Cited by 584
(1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301204 · Cited by 577
Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia
Hansen, J. A., Gooley, T. A., Martin, P. J., Appelbaum, F., Chauncey, T. R., Clift, R. A., Petersdorf, E. W., Radich, J., Sanders, J. E., Storb, R. F., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804023381405 · Cited by 570
Carroll, M., Ohno-Jones, S., Tamura, S., Buchdunger, E., Zimmermann, J., Lydon, N. B., Gilliland, D. G., & Druker, B. J. (1997) · Blood · doi:10.1182/blood.v90.12.4947 · Cited by 554
Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia
Guilhot, F., Chastang, C., Michallet, M., Guerci, A., Harousseau, J.-L., Maloisel, F., Bouabdallah, R., Guyotat, D., Cheron, N., Nicolini, F., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370402 · Cited by 543
Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia
Bedi, A., Zehnbauer, B., Barber, J., Sharkis, S., & Jones, R. (1994) · Blood · doi:10.1182/blood.v83.8.2038.2038 · Cited by 508
le Coutre, P., Tassi, E., Varella-Garcia, M., Barni, R., Mologni, L., Cabrita, G., Marchesi, E., Supino, R., & Gambacorti-Passerini, C. (2000) · Blood · doi:10.1182/blood.v95.5.1758.005a41_1758_1766 · Cited by 484
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells
Deininger, M. W. N., Goldman, J. M., Lydon, N., & Melo, J. V. (1997) · Blood · doi:10.1182/blood.v90.9.3691 · Cited by 482
Szydlo, R., Goldman, J. M., Klein, J. P., Gale, R. P., Ash, R. C., Bach, F. H., Bradley, B. A., Casper, J. T., Flomenberg, N., Gajewski, J. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1767 · Cited by 468
Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 450
Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.
Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P. G., Arlinghaus, R., & Pawson, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06319.x · Cited by 438
Gordon, M. Y., Dowding, C. R., Riley, G. P., Goldman, J. M., & Greaves, M. F. (1987) · Nature · doi:10.1038/328342a0 · Cited by 436
Kantarjian, H. M., Smith, T. L., O'Brien, S., Beran, M., Pierce, S., Talpaz, M., & Service*, A. T. L. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-4-199502150-00003 · Cited by 417
Weisberg, E., & Griffin, J. D. (2000) · Blood · doi:10.1182/blood.v95.11.3498 · Cited by 401
BONE MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Ansen, J. O. A. H., Ooley, A. G., Artin, P. A. J. M., et al. (1998) · Cited by 400
Allan, N. C., Shepherd, P. C. A., & Richards, S. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92596-1 · Cited by 388
In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor
le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., & Gambacorti-Passerini, C. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.163 · Cited by 374
Carpino, N., Wisniewski, D., Strife, A., Marshak, D., Kobayashi, R., Stillman, B., & Clarkson, B. (1997) · Cell · doi:10.1016/s0092-8674(00)81840-1 · Cited by 362
Identification of the Abl- and rasGAP-Associated 62 kDa Protein as a Docking Protein, Dok
Yamanashi, Y., & Baltimore, D. (1997) · Cell · doi:10.1016/s0092-8674(00)81841-3 · Cited by 345
Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia
Talpaz, M., McCredie, K., Mavligit, G., & Gutterman, J. (1983) · Blood · doi:10.1182/blood.v62.3.689.689 · Cited by 336
Vigneri, P., & Wang, J. Y. J. (2001) · Nature Medicine · doi:10.1038/84683 · Cited by 331
Gambacorti-Passerini, C. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1641 · Cited by 320
Kilic, T., Alberta, J. A., Zdunek, P. R., Acar, M., Iannarelli, P., O'Reilly, T., Buchdunger, E., Black, P. M., & Stiles, C. D. (2000) · PubMed · Cited by 310
Thiesing, J. T., Ohno-Jones, S., Kolibaba, K. S., & Druker, B. J. (2000) · Blood · doi:10.1182/blood.v96.9.3195 · Cited by 309
Protein tyrosine kinases and cancer
Kolibaba, K. S., & Druker, B. J. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00022-x · Cited by 291
Chronic Myeloid Leukemia Trialists' Collaborative Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1616 · Cited by 283
Westbrook, C., Hooberman, A., Spino, C., Dodge, R., Larson, R., Davey, F., Wurster- Hill, D., Sobol, R., Schiffer, C., & Bloomfield, C. (1992) · Blood · doi:10.1182/blood.v80.12.2983.2983 · Cited by 274
Fang, G., Kim, C. N., Perkins, C. L., Ramadevi, N., Winton, E., Wittmann, S., & Bhalla, K. N. (2000) · Blood · doi:10.1182/blood.v96.6.2246 · Cited by 269
Cortez, D., Kadlec, L., & Pendergast, A. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5531 · Cited by 267
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
Goldman, J. M., & Melo, J. V. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441409 · Cited by 265
The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.
Krystal, G. W., Honsawek, S., Litz, J., & Buchdunger, E. (2000) · PubMed · Cited by 265
Wang, W.-L., Healy, M. E., Sattler, M., Verma, S., Lin, J., Maulik, G., Stiles, C. D., Griffin, J. D., Johnson, B. E., & Salgia, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203698 · Cited by 234
Chronic myeloid leukemia: current treatment options
Goldman, J. M., & Druker, B. J. (2001) · Blood · doi:10.1182/blood.v98.7.2039 · Cited by 224
Hehlmann, R., Heimpel, H., Hasford, J., Kolb, H., Pralle, H., Hossfeld, D., Queisser, W., Loffler, H., Heinze, B., & Georgii, A. (1993) · Blood · doi:10.1182/blood.v82.2.398.398 · Cited by 223
BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
Voncken, J., Kaartinen, V, Pattengale, P., Germeraad, W., Groffen, J., & Heisterkamp, N. (1995) · Blood · doi:10.1182/blood.v86.12.4603.bloodjournal86124603 · Cited by 216
The biology and treatment of acute lymphoblastic leukemia in adults
Copelan, E., & McGuire, E. (1995) · Blood · doi:10.1182/blood.v85.5.1151.bloodjournal8551151 · Cited by 211
Ohnishi, K., Ohno, R., Tomonaga, M., Kamada, N., Onozawa, K., Kuramoto, A., Dohy, H., Mizoguchi, H., MIYAWAKI, S., & Tsubaki, K. (1995) · Blood · doi:10.1182/blood.v86.3.906.906 · Cited by 190
Sacchi, S., Kantarjian, H. M., O'Brien, S., Cortes, J., Rios, M. B., Giles, F. J., Beran, M., Koller, C. A., Keating, M. J., & Talpaz, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991215)86:12<2632::aid-cncr7>3.0.co;2-a · Cited by 184
Goldman, J. M., Szydlo, R., Horowitz, M., Rp, G., Ash, R., Atkinson, K., Ka, D., Gluckman, É., Herzig, R. H., & Marmont, A. (1993) · Blood · doi:10.1182/blood.v82.7.2235.2235 · Cited by 181
Beran, M., Cao, X., Estrov, Z., Jeha, S., Jin, G., O'Brien, S. M., Talpaz, M., Arlinghaus, R. B., Lydon, N., & Kantarjian, H. M. (1998) · PubMed · Cited by 176
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells
Mandanas, R., Leibowitz, D., Gharehbaghi, K., Tauchi, T., Burgess, G., Miyazawa, K., Jayaram, H., & Boswell, H. (1993) · Blood · doi:10.1182/blood.v82.6.1838.1838 · Cited by 165
Ozer, H., George, S., Schiffer, C., Rao, K., Rao, P., Wurster-Hill, D., Arthur, D., Powell, B., Gottlieb, A., & Peterson, B. (1993) · Blood · doi:10.1182/blood.v82.10.2975.2975 · Cited by 165
van Rhee, F., Szydlo, R., Hermans, J., Devergié, A., Frassoni, F., Arcese, W., de Witte, T., Kolb, H., Niederwiser, D., Jacobsen, N. O., et al. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700933 · Cited by 165
Lee, S. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02216.x · Cited by 143
Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group
Cohen, P., Chan, J., Lipkunskaya, M., Biedler, J. L., & Seeger, R. C. (1994) · Blood · doi:10.1182/blood.v84.10.3465.3465 · Cited by 138
Deininger, M. W., Vieira, S., Mendiola, R., Schultheis, B. S., Goldman, J. M., & Melo, J. V. (2000) · PubMed · Cited by 137
Blast crisis in a murine model of chronic myelogenous leukemia.
Daley, G. Q., Etten, R. A. V., & Baltimore, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11335 · Cited by 116
Reichert, A., Heisterkamp, N., Daley, G. Q., & Groffen, J. (2001) · Blood · doi:10.1182/blood.v97.5.1399 · Cited by 114
Beelen, D., Graeven, U., Elmaagacli, A. H., Niederle, N., Kloke, O., Opalka, B., & Schaefer, U. (1995) · Blood · doi:10.1182/blood.v85.10.2981.bloodjournal85102981 · Cited by 114
Signal transduction by wild-type and leukemogenic Abl proteins
Raitano, A. B., Whang, Y. E., & Sawyers, C. L. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00023-1 · Cited by 102
Morton, A. J., Gooley, T. A., Hansen, J. A., Appelbaum, F. R., Bruemmer, B., Bjerke, J. W., Clift, R., Martin, P. J., Petersdorf, E. W., Sanders, J. E., et al. (1998) · Blood · doi:10.1182/blood.v92.2.394 · Cited by 97
Hehlmann, R., Hochhaus, A., Kolb, H., Hasford, J., Gratwohl, A. A., Heimpel, H., Siegert, W., Finke, J., Ehninger, G., Holler, E., et al. (1999) · Blood · doi:10.1182/blood.v94.11.3668 · Cited by 92
Barnhill, R. L., Xiao, M., Graves, D. T., & Antoniades, H. N. (1996) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1996.d01-1092.x · Cited by 85
Laneuville, P., Sun, G., Timm, M., & Vekemans, M. J. J. (1992) · Blood · doi:10.1182/blood.v80.7.1788.1788 · Cited by 76
Bhatia, R., & Verfaillie, C. M. (1998) · Blood · doi:10.1182/blood.v91.9.3414 · Cited by 68
Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
Strife, A., Lambek, C. L., Wisniewski, D. J., Wachter, M., Gulati, S. C., & Clarkson, B. D. (1988) · PubMed · Cited by 58
Kantarjian, H. M., Talpaz, M., Keating, M. J., Estey, E. H., O'Brien, S. M., Beran, M., McCREDIE, K. B., Gutterman, J. U., & Freireich, E. J. (1991) · Cancer · doi:10.1002/1097-0142(19910915)68:6<1201::aid-cncr2820680604>3.0.co;2-1 · Cited by 53
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia
Goldman, J. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02029-8 · Cited by 51
Holyoake, T. L. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02558.x · Cited by 50
Talpaz, M. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90114-3 · Cited by 43
Novel therapies for chronic myelogenous leukemia
Jahagirdar, B., Miller, J. S., Shet, A. S., et al. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00633-6 · Cited by 41
Tyrosine kinase inhibitors in chronic myeloid leukemia.
Sawyers, C. L., & Druker, B. J. (1999) · PubMed · Cited by 35
Walters, R. S., Kantarjian, H. M., Keating, M. J., Talpaz, M., Childs, C. C., McCREDIE, K. B., & Freireich, E. J. (1987) · Cancer · doi:10.1002/1097-0142(19871015)60:8<1708::aid-cncr2820600803>3.0.co;2-1 · Cited by 30
Grignani, F. (1985) · PubMed · Cited by 21
Cited by
Kris, M. G., Natale, R. B., Herbst, R. S., Lynch, Jr., Prager, D., Belani, C. P., Schiller, J. H., Kelly, K., Spiridonidis, H., Sandler, A., et al. (2003) · JAMA · doi:10.1001/jama.290.16.2149 · Cited by 2,517
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Baccarani, M., Cortes, J., Pane, F., Niederwieser, D., Saglio, G., Apperley, J., Cervantes, F., Deininger, M., Gratwohl, A., Guilhot, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0779 · Cited by 1,291
Baccarani, M. (2006) · Blood · doi:10.1182/blood-2006-02-005686 · Cited by 1,277
Role of Tyrosine Kinase Inhibitors in Cancer Therapy
Arora, A., & Scholar, E. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084145 · Cited by 1,014
Metadata
- Authors
- Savage, D. G., & Antman, K. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-28
- Volume
- 346
- Issue
- 9
- Pages
- 683-693
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2039045990
- Cited by
- 844
- References
- 95
- FWCI
- 34.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.